MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing
Aberrant alternative splicing has been shown to contribute to the tumorigenic processes. Here, the authors show that MTR4 is overexpressed in hepatocellular carcinoma and has a role in tumorigenesis through the modulation of the splicing of glycolytic genes PKM2 and GLUT1.
Enregistré dans:
Auteurs principaux: | Lili Yu, Jinchul Kim, Lei Jiang, Bingbing Feng, Yue Ying, Kai-yuan Ji, Qingshuang Tang, Wancheng Chen, Taoyi Mai, Wenlong Dou, Jianlong Zhou, Le-yang Xiang, Yang-fan He, Dinghua Yang, Qingjiao Li, Xuemei Fu, Yang Xu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d6f7056973d7420fa80b0b12ab8c2f6e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of prognostic alternative splicing events in sarcoma
par: Hongshuai Li, et autres
Publié: (2021) -
Alternative splicing regulates distinct subcellular localization of Epithelial splicing regulatory protein 1 (Esrp1) isoforms
par: Yueqin Yang, et autres
Publié: (2017) -
Alternative splicing level related to intron size and organism complexity
par: Pengcheng Yang, et autres
Publié: (2021) -
Alternative splicing acts as an independent prognosticator in ovarian carcinoma
par: Yan Ouyang, et autres
Publié: (2021) -
Alternative Splicing in Apicomplexan Parasites
par: Lee M. Yeoh, et autres
Publié: (2019)